Cargando…
Characterization of Domiphen Bromide as a New Fast-Acting Antiplasmodial Agent Inhibiting the Apicoplastidic Methyl Erythritol Phosphate Pathway
The evolution of resistance by the malaria parasite to artemisinin, the key component of the combination therapy strategies that are at the core of current antimalarial treatments, calls for the urgent identification of new fast-acting antimalarials. The apicoplast organelle is a preferred target of...
Autores principales: | Biosca, Arnau, Ramírez, Miriam, Gomez-Gomez, Alex, Lafuente, Aritz, Iglesias, Valentín, Pozo, Oscar J., Imperial, Santiago, Fernàndez-Busquets, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319574/ https://www.ncbi.nlm.nih.gov/pubmed/35890216 http://dx.doi.org/10.3390/pharmaceutics14071320 |
Ejemplares similares
-
Data on thermal and hydrolytic stability of both domiphen bromide and para-bromodomiphen bromide
por: Fumagalli, Laura, et al.
Publicado: (2018) -
Combining Miconazole and Domiphen Bromide Results in Excess of Reactive Oxygen Species and Killing of Biofilm Cells
por: Tits, Jana, et al.
Publicado: (2021) -
An ImmunoPEGliposome for Targeted Antimalarial Combination Therapy at the Nanoscale
por: Biosca, Arnau, et al.
Publicado: (2019) -
Combination of AgNPs and Domiphen is Antimicrobial Against Biofilms of Common Pathogens
por: Hu, Longhao, et al.
Publicado: (2021) -
Selection of an Aptamer against the Enzyme 1-deoxy-D-xylulose-5-phosphate Reductoisomerase from Plasmodium falciparum
por: Roca, Carlota, et al.
Publicado: (2022)